Complications and Adverse Events of Gonadal Vein Embolization with Coils

Sergey G Gavrilov1, Nadezhda Y Mishakina1, Oksana I Efremova1

  • 1Department of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, Moscow 119049, Russia.

Insights

Gonadal vein embolization (GVE) for pelvic venous disease (PeVD) effectively reduces chronic pelvic pain (CPP) in most patients. However, GVE is associated with specific complications, including pelvic vein thrombosis, necessitating careful patient selection and monitoring.

Area of Science:

  • Interventional Radiology
  • Vascular Medicine
  • Gynecology

Background:

  • The efficacy and safety of gonadal vein embolization (GVE) using coils for treating pelvic venous disease (PeVD) remain incompletely understood.
  • Patient and physician expectations are not always met by GVE outcomes, highlighting a need to investigate associated complications.

Purpose of the Study:

  • To assess the incidence and causes of complications following GVE with coils in patients diagnosed with PeVD.
  • To evaluate the effectiveness of GVE in alleviating chronic pelvic pain (CPP) and identify associated adverse events.

Main Methods:

  • A retrospective cohort study involving 150 female patients with PeVD who underwent GVE with coils between 2000 and 2020.
  • Complication rates were assessed 30 days post-GVE using the Society for Interventional Radiology (SIR) classification.
  • Pain severity was measured using the visual analogue scale (VAS), with duplex ultrasound and CT venography used for follow-up.

Main Results:

  • Chronic pelvic pain (CPP) decreased in 72.6% of patients post-GVE (mean VAS from 8.2 to 1.7).
  • Post-embolic syndrome (PES) occurred in 22% of patients, resolving within one month, with an overall GVE efficacy of 94.6% after PES resolution.
  • Complications were observed in 34.6% of patients, including minor events (hematoma, allergic reactions) and major events (coil protrusion, parametrial/uterine vein thrombosis [21.3%], deep calf vein thrombosis [2.7%]).

Conclusions:

  • Gonadal vein embolization (GVE) with coils for PeVD is linked to specific complications, with pelvic vein thrombosis being the most frequent.
  • Post-embolization syndrome (PES) should be recognized as a potential adverse event of GVE procedures.
  • Despite complications, GVE demonstrates significant efficacy in pain relief for a majority of patients with PeVD.

Related Concept Videos

Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
23
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
23
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
26
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
92